Thus, we though that the reverse binding order (IL13 binds to IL13Rαl and then IL4 binds to IL4Rα) might cause abrogate the functional complex forming of type II IL4R, which lead to inhibit RCC development and prolong the survival rate of RCC patients. This evidence concerns the gene IL13 and renal cell carcinoma.